IPP Bureau
Enhertu approved in EU in post-ET breast cancer
By IPP Bureau - April 04, 2025
Approval brings AstraZeneca and Daiichi Sankyo’s Enhertu earlier in the treatment of HR-positive, HER2-low breast cancer and broadens the eligible patient population to those with HER2-ultralow disease
Avantor bags awards at Asia-Pacific Biopharma Excellence Awards 2025
By IPP Bureau - April 04, 2025
Awards highlight Avantor's commitment to the Biopharma industry
Naturo & Orgo empowering brands through excellence
By IPP Bureau - April 03, 2025
The company offers customized formulations tailored to align with each brand’s identity and consumer needs
Knya forays into medical equipment category with '6sense Stethoscope'
By IPP Bureau - April 03, 2025
The stethoscope features high acoustic sensitivity and active noise cancellation, minimizing ambient interference to improve auscultation clarity, particularly in noisy hospital settings
Alembic announces USFDA final approval for Pantoprazole Sodium for Injection, 40 mg/vial
By IPP Bureau - April 03, 2025
Pantoprazole Sodium for Injection, 40 mg/vial (Single-Dose Vial) have an estimated market size of US$ 48 million for twelve months ending December 2024 according to IQVIA
Asahi Kasei Life Science begins operation
By IPP Bureau - April 03, 2025
Being a premium partner for pharmaceutical companies by contributing to safety and productivity of pharmaceutical manufacture
Amcor's Bloom Biorenewables secures $14 million Series A Funding
By IPP Bureau - April 03, 2025
Bloom has pioneered a technology to transform plant waste into valuable chemical products
Peter Bains appointed MD & CEO of Syngene International
By IPP Bureau - April 02, 2025
He has global experience in strategic and operational leadership levels with an extensive track record of leadership and success in building companies, businesses, teams, and brands for over 30 years
Glenmark Pharmaceuticals USA launches Vancomycin Hydrochloride for Injection
By IPP Bureau - April 02, 2025
According to IQVIA sales data for the 12-month period ending January 2025, the Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-dose vial) market achieved annual sales of approximately $39.3 mn
Emcutix and WiQo sign licensing partnership for derma-cosmetic treatments in India
By IPP Bureau - April 02, 2025
PRX-PLUS has a unique product feature with its deep-impacting formula
SK Capital invests in Spectrum Vascular
By IPP Bureau - April 02, 2025
Founded in 2023, Spectrum Vascular acquired the vascular access businesses of Cook Medical in 2023 and AngioDynamics in 2024
Coveris launches circular solution for stretch sleeves with ReCover
By IPP Bureau - April 02, 2025
The introduction of Coveris’ sleeve-to-sleeve PCR model complements sectors such as bottling where an established recycling infrastructure exists
Morrisons introduces sensory support boxes in store for autistic and neurodiverse customers
By IPP Bureau - April 02, 2025
Sensory Boxes include items such as drawing boards and fidget balls to support management of anxiety and improve shopping experience
Shin-Etsu Chemical to invest in pharmaceutical cellulose business
By IPP Bureau - April 01, 2025
L-HPC was independently developed by Shin-Etsu Chemical as a disintegrant for tablets
